
South Korean internet giant Naver is acquiring US e-retailer Poshmark for roughly $1.2 billion, the companies announced Monday. Poshmark shares popped as much as 14% in extended trading.
Naver operates a search engine, e-commerce platform and other services in South Korea. The companies said the deal will deepen Naver’s reach in online retail, while allowing Poshmark to enter international markets.
Poshmark is a popular online retail site that lets people shop from the closets of other users. The company went public in January 2021 at $42 a share, hitting the market at a time when online shopping was surging due to the Covid-19 pandemic and investors were flocking to tech stocks.
Since then, the stock has fallen sharply, tumbling alongside the rest of the tech industry.
Naver and Poshmark said they expect the deal to generate “significant revenue and cost synergies,” including re-acceleration of annual revenue growth beyond 20% in the near term, as ads improve monetization, investments grow overseas and live commerce gets greater adoption.
The deal adds to recent consolidation in the secondhand clothing market. Etsy acquired fashion resale app Depop for $1.62 billion last year. Depop competes with Poshmark and other resale services like ThredUp.
The companies will host a conference call to discuss the deal at 9 p.m. ET on Monday.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas